A RANDOMIZED COMPARISON OF DOXIFLURIDINE AND FLUOROURACIL IN COLORECTAL-CARCINOMA

被引：34

作者：

ALBERTO, P

MERMILLOD, B

GERMANO, G

KAPLAN, S

WEBER, W

JOSS, R

SPATI, B

MARTZ, G

CAVALLI, F

机构：

[1] UNIV GENEVA,HOP CANTONAL,DIV INFORMAT,CH-1211 GENEVA 4,SWITZERLAND

[2] HOFFMANN LA ROCHE & CO LTD,BASEL,SWITZERLAND

[3] SAN GIOVANNI HOSP,DIV ONCOL,CH-6500 BELLINZONA,SWITZERLAND

[4] INSELSPITAL,INST CLIN ONCOL,CH-3010 BERN,SWITZERLAND

[5] KANTONSSPITAL,DEPT MED C,DIV ONCOL,CH-9006 ST GALLEN,SWITZERLAND

[6] HOSP SAN GIOVANNI,DIV ONCOL,SWISS GRP CLIN CANC RES,CH-6500 BELLINZONA,SWITZERLAND

[7] UNIV HOSP ZURICH,DIV ONCOL,CH-8000 ZURICH,SWITZERLAND

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 03期

关键词：

D O I：

10.1016/S0277-5379(98)90037-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：559 / 563

页数：5

共 21 条

[1] PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
ABELE, R
KAPLAN, E
GROSSENBACHER, R
SCHMID, HJ
CAVALLI, F
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (03): : 333 - 336
[2] PHASE-II STUDY OF DOXIFLURIDINE IN ADVANCED COLORECTAL ADENOCARCINOMA
ABELE, R
ALBERTO, P
KAPLAN, S
SIEGENTHALER, P
HOFMANN, V
RYSSEL, HJ
HARTMANN, D
HOLDENER, EE
CAVALLI, F
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (12) : 750 - 754
[3] ABELE R, 1982, CANCER TREAT REP, V66, P1307
[4] ALBERTO P, 1986, CANCER CHEMOTH PHARM, V16, P78
[5] A PHASE-II STUDY OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED BREAST-CANCER
ALBERTO, P
JUNGI, WF
SIEGENTHALER, P
MERMILLOD, B
OBRECHT, JP
DECOSTER, G
CAVALLI, F
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03): : 565 - 566
[6] [Anonymous], 1979, WHO HDB REPORTING RE
[7] PHASE I-II STUDIES OF ORAL TEGAFUR (FTORAFUR)
ANSFIELD, FJ
KALLAS, GJ
SINGSON, JP
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (02) : 107 - 110
[8] ARMSTRONG RD, 1983, CANCER RES, V43, P2525
[9] ARMSTRONG RD, 1980, CANCER RES, V40, P3333
[10] ARMSTRONG RD, 1983, CANCER TREAT REP, V67, P541